glp 1 agonist perioperative Holding GLP-1 Agonists Prior to Elective Procedures How should we approach patients

Zhang H, Zhou H, Shen X, et al

The April 2026 FDA action removes them from the Category 2 restricted compounding list effective April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review their compounding eligibility under 503A at its July 23-24, 2026 meeting

Research Applications Energy Metabolism and Mitochondrial Function Studies L-Carnitine serves as a fundamental research tool for investigating cellular energy metabolism: Fatty Acid Oxidation Research: Investigation of beta-oxidation pathways, substrate utilization, and metabolic flux between glucose and fatty acid oxidation

Pregnancy and breastfeeding You shouldnt take GLP-1 agonist drugs during pregnancy

Further research by Gobburu et al